Capital Research Global Investors
ABBV icon

Capital Research Global Investors’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.69B Sell
25,265,579
-8,242,435
-25% -$1.53B 0.94% 24
2025
Q1
$7.02B Sell
33,508,014
-475,693
-1% -$99.7M 1.53% 14
2024
Q4
$6.04B Buy
33,983,707
+778,126
+2% +$138M 1.24% 19
2024
Q3
$6.56B Buy
33,205,581
+20,187
+0.1% +$3.99M 1.36% 16
2024
Q2
$5.69B Buy
33,185,394
+1,890,244
+6% +$324M 1.25% 18
2024
Q1
$5.7B Buy
31,295,150
+992,496
+3% +$181M 1.29% 14
2023
Q4
$4.7B Sell
30,302,654
-1,673,490
-5% -$259M 1.16% 18
2023
Q3
$4.77B Sell
31,976,144
-569,378
-2% -$84.9M 1.31% 14
2023
Q2
$4.38B Sell
32,545,522
-3,168,845
-9% -$427M 1.18% 17
2023
Q1
$5.69B Sell
35,714,367
-997,422
-3% -$159M 1.62% 12
2022
Q4
$5.93B Buy
36,711,789
+518,687
+1% +$83.8M 1.79% 8
2022
Q3
$4.86B Buy
36,193,102
+9,896,885
+38% +$1.33B 1.6% 11
2022
Q2
$4.03B Buy
26,296,217
+9,216,006
+54% +$1.41B 1.25% 16
2022
Q1
$2.77B Sell
17,080,211
-925,618
-5% -$150M 0.68% 35
2021
Q4
$2.44B Sell
18,005,829
-1,004,082
-5% -$136M 0.54% 42
2021
Q3
$2.05B Buy
19,009,911
+324,445
+2% +$35M 0.48% 50
2021
Q2
$2.1B Sell
18,685,466
-1,535,173
-8% -$173M 0.49% 43
2021
Q1
$2.19B Sell
20,220,639
-17,700,423
-47% -$1.92B 0.54% 40
2020
Q4
$4.06B Sell
37,921,062
-2,883,051
-7% -$309M 1.05% 21
2020
Q3
$3.57B Sell
40,804,113
-5,299,576
-11% -$464M 1.07% 19
2020
Q2
$4.53B Sell
46,103,689
-3,128,616
-6% -$307M 1.43% 12
2020
Q1
$3.75B Sell
49,232,305
-37,370,388
-43% -$2.85B 1.47% 12
2019
Q4
$7.67B Sell
86,602,693
-14,011,979
-14% -$1.24B 2.3% 8
2019
Q3
$7.62B Sell
100,614,672
-9,509,347
-9% -$720M 2.5% 5
2019
Q2
$8.01B Sell
110,124,019
-36,384,326
-25% -$2.65B 2.54% 5
2019
Q1
$11.8B Sell
146,508,345
-27,059,898
-16% -$2.18B 3.74% 2
2018
Q4
$16B Sell
173,568,243
-2,571,964
-1% -$237M 5.58% 1
2018
Q3
$16.7B Sell
176,140,207
-17,628,648
-9% -$1.67B 4.84% 1
2018
Q2
$18B Buy
193,768,855
+686,114
+0.4% +$63.6M 4.9% 1
2018
Q1
$18.3B Buy
193,082,741
+71,968
+0% +$6.81M 5.2% 1
2017
Q4
$18.7B Buy
193,010,773
+3,995,594
+2% +$386M 5.48% 1
2017
Q3
$16.8B Buy
189,015,179
+10,740,344
+6% +$954M 5.07% 1
2017
Q2
$12.9B Buy
178,274,835
+2,130,919
+1% +$155M 4.05% 1
2017
Q1
$11.5B Buy
176,143,916
+1,180,164
+0.7% +$76.9M 3.62% 1
2016
Q4
$11B Buy
174,963,752
+13,688,625
+8% +$857M 3.55% 1
2016
Q3
$10.2B Buy
161,275,127
+8,556,414
+6% +$539M 3.36% 2
2016
Q2
$9.44B Buy
152,718,713
+76,593,054
+101% +$4.73B 3.23% 2
2016
Q1
$4.35B Sell
76,125,659
-1,443,000
-2% -$82.4M 1.5% 11
2015
Q4
$4.6B Buy
77,568,659
+2,635,205
+4% +$156M 1.57% 11
2015
Q3
$4.08B Sell
74,933,454
-8,035,764
-10% -$437M 1.46% 11
2015
Q2
$5.57B Sell
82,969,218
-7,484,916
-8% -$503M 1.83% 8
2015
Q1
$5.3B Sell
90,454,134
-10,098,455
-10% -$591M 1.81% 9
2014
Q4
$6.58B Sell
100,552,589
-12,029,000
-11% -$787M 2.23% 7
2014
Q3
$6.5B Buy
112,581,589
+9,693,000
+9% +$560M 2.25% 6
2014
Q2
$5.81B Buy
102,888,589
+965,200
+0.9% +$54.5M 2.03% 8
2014
Q1
$5.24B Buy
101,923,389
+1,961,264
+2% +$101M 1.89% 9
2013
Q4
$5.28B Sell
99,962,125
-4,818,713
-5% -$254M 1.95% 8
2013
Q3
$4.69B Sell
104,780,838
-2,830,000
-3% -$127M 1.85% 9
2013
Q2
$4.45B Buy
+107,610,838
New +$4.45B 1.89% 8